학술논문
Case report: Continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung disease
Document Type
Article
Author
Source
In: BMC Pulmonary Medicine . (BMC Pulmonary Medicine, 6 December 2017, 17(1))
Subject
Language
English
ISSN
14712466